Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Using both vertical and transverse sections for alopecia biopsies improves diagnosis without extra cost.

The patient's liver did not fully grow back and she had serious temporary side effects after a very large liver surgery.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Stress might contribute to hair loss in alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

FFA's causes may include environmental triggers and genetic factors.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Guidelines help design better trials to compare alopecia areata treatments.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.